Drug Manufacturers - Specialty & Generic · Woburn, Massachusetts, United States
$1.48
+0.00% (+$0.00)2026-08-21
Smart-Money SignalNeutral · 48/100— Insider open-market flow is flat over 90 days
Revenue$12.0M
Net Income-$604.0K
EPS$-0.44
Market Cap$21.0M
Price Performance
Historical data including institutional events
Company Profile
H
Hermann Luebbert
CEO & Executive Director
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.
The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.